ZEUS System
Overview
The ZEUS (Zio ECG Utilization Software) System is an artificial intelligence (AI) algorithm and software component integral to iRhythm Technologies’ cardiac monitoring solutions, including the Zio Watch and Zio monitors. It is designed for non-invasive, clinical-grade, long-term continuous monitoring to detect and characterize cardiac arrhythmias, particularly Atrial Fibrillation (AFib). The system processes continuous electrocardiogram (ECG) data using proprietary deep-learned algorithms, distilling millions of heartbeats into clinically actionable information. Certified Cardiographic Technicians (CCTs) review the algorithm-labeled ECG data before generating preliminary reports for physicians. These reports are provided to clinicians via a secure website to aid in arrhythmia diagnosis and management, integrating with existing clinician workflows and care pathways. The ZEUS System is indicated for use on patients 18 years or older who may be asymptomatic or suffer from transient symptoms such as palpitations, shortness of breath, dizziness, light-headedness, pre-syncope, syncope, fatigue, or anxiety.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-powered arrhythmia detection
- Continuous ECG monitoring (up to 14 days)
- Cloud-based data analytics
- Detection and characterization of Atrial Fibrillation (AFib)
- Preliminary report generation for physicians
- Integration with Zio Watch and Zio monitors
- Support for symptomatic and asymptomatic cardiac events
- HL7-based EHR integration
- Secure web portal for report access (ZioSuite)
- Mobile application for healthcare professionals (ZioSuite)
Use Cases
- Long-term continuous monitoring for atrial fibrillation (AFib)
- Aid in arrhythmia diagnosis and management
- Proactive identification of elevated arrhythmia risk in patients with comorbid conditions (e.g., Type 2 diabetes, chronic kidney disease, COPD, coronary artery disease)
- Ambulatory Mobile Cardiac Telemetry (MCT) monitoring
- Streamlining clinical workflows for cardiac care
What Physicians Need to Know
The ZEUS System is designed for adult patients (18 years or older) experiencing symptomatic or asymptomatic transient cardiac symptoms. It is crucial to note that it is contraindicated for critical care patients or those with conditions requiring immediate real-time monitoring for life-threatening arrhythmias. Clinicians should use the provided preliminary reports as an aid in diagnosis, applying their clinical judgment and experience. Accurate and complete patient registration is essential to prevent potential misdiagnosis or erroneous reporting. Be aware of transmission limits on Zio AT devices, as reaching these limits will halt the transmission of event data for review during the wear period.
The ZEUS System is deeply integrated into the iRhythm Zio Service ecosystem, working seamlessly with Zio wearable monitors like the Zio Watch and Zio AT patch. The ZioSuite web portal and mobile application, a module of ZEUS, streamline clinical workflows by enabling patient enrollment, access to clinical reports, and report interpretation. The system also offers HL7-based EHR integration for broader compatibility within healthcare IT infrastructures.
Details
| Category | Cardiology AI, Wearables & Remote Monitoring (RPM) |
| Pricing | Not disclosed — N/A |
| Deployment | Cloud-based (AWS EC2 platform), no on-premise hardware. |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
1 AI-estimated The ZEUS System (K222389) received FDA 510(k) clearance on February 15, 2023, as a programmable diagnostic computer. It is part of the Zio Service and Zio AT device for ambulatory Mobile Cardiac Telemetry (MCT) monitoring. |
| Integrations | |
| EHR | Not specified |
| Specialties | Cardiology, Family Medicine, Internal Medicine |
What the Web Says
The iRhythm ZEUS (Zio ECG Utilization Software) System, developed in partnership with Verily, is an AI-powered, FDA-cleared solution for long-term, non-invasive continuous monitoring of atrial fibrillation (AFib) using the Zio Watch. It aims to improve arrhythmia detection and characterization, providing clinicians with preliminary reports to aid in diagnosis and intervention. While praised for its ease of use and comprehensive reporting, some users have reported technical issues and concerns regarding billing practices.
Overall: MixedStrengths
- User-friendly and easy to navigate interface.
- Provides clinical-grade, long-term, non-invasive continuous monitoring for AFib.
- Utilizes AI-based algorithms for accurate AFib detection and burden estimation.
- Generates comprehensive, physician-agreed-upon preliminary reports for diagnosis.
- Integrates with clinician workflows and aims to improve patient experience.
- Effective in detecting various arrhythmias beyond AFib.
Limitations
- Reports of frequent system crashes and unreliability.
- Poor design limits essential information visibility.
- Patient data can become inaccessible if device registration is incomplete.
- Transmission limits on patient-triggered and automatically detected arrhythmia events can lead to incomplete data for high-risk patients.
- Not intended for critical care patients or situations requiring real-time monitoring.
- Some users have reported issues with adhesive causing skin irritation and slow turnaround times for reports.
Based on reviews from: G2, Capterra, iRhythm Technologies, Cardiac Rhythm News, DAIC, Medical Product Outsourcing, Fierce Biotech, FDA, Reddit, Better Business Bureau
Last updated: 2026-07-18
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate ZEUS System
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for ZEUS System.
AI Agent Powered AI/ML-Enabled Medical Devices Compliance Platform Use Case for Cardiovascular Care
Frequently Asked Questions
Compare ZEUS System
VS
VS
VS
VS
Investors who backed ZEUS System
Funded through the company that built this tool.
